Peri-operative management of an adult patient with type 2N von Willebrand's disease scheduled for coronary artery bypass graft

Anaesthesia

Volumn 62, Issue 4, 2007, Pages 405-408

  Gerling, V ^a   Lahpor, J R ^a   Buhre, W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; RISTOCETIN; VON WILLEBRAND FACTOR;

AGED; ARTICLE; BLEEDING TIME; BOLUS INJECTION; CARDIOPULMONARY BYPASS; CASE REPORT; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG DOSE INCREASE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEPARINIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PROTEIN BLOOD LEVEL; THROMBOSIS PREVENTION; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 2N;

AGED; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; CORONARY ARTERY BYPASS; FACTOR VIII; HUMANS; MALE; PERIOPERATIVE CARE; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33947672856     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05001.x     Document Type: Article

References (12)

1. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. New England Journal of Medicine 2003; 24: 343-9.
2. Sadler JE. Aortic stenosis, von Willebrand factor, and bleeding. New England Journal of Medicine 2003; 24: 323-5.
3. Gartner V, Oehler L. Acquired von Willebrand syndrome type IIA in a patient with aortic valve stenosis and myeloproliferative disorder. Annals of Hematology 2006; 85: 200-1.
4. Cameron CB, Kobrinsky N. Perioperative management of patients with von Willebrand's disease. Canadian Journal of Anaesthesia 1990; 37: 341-7.
5. Kuehne T, Imbach P, Marbet GA, Caliezi C, Devay J. Continuous infusion of von Willebrand factor and factor VIII after elective heart surgery in a 12-year-old girl with von Willebrand disease type 3. Pediatric Hematology Oncology 1999; 16: 551-6.
6. Tatebe S, Kanazawa H, Yamazaki Y, Aoki E, Sakurai Y, Miyamura H. Closure of a ventricular septal defect in a patient with von Willebrand disease. Surgery Today 1997; 27: 661-3.
7. Michiels JJ, Berneman ZN, Planken M vd, Schroyens W, Budde U, Vliet HHDM v. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P). Blood Coagulation and Fibrinolysis 2004; 15: 323-30.
8. Chun PKC, Flannery EP, Bowen TE. Open-heart surgery in patients with hematologic disorders. American Heart Journal 1983; 105: 835-42.
9. Federici AB. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: Results from current studies and surveys. Blood Coagulation and Fibrinolysis 2005; 16 (Suppl. 1): S17-S21.
10. Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia 2004; 10 (Suppl. 4): 169-76.
11. Mannucci PM. Venous thrombosis in von Willebrand disease. Thrombosis and Haemostasis 2002; 88: 378-9.
12. Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease. Thrombosis and Haemostasis 2002; 88: 387-8.